Molecular Mechanisms of Neurodegeneration
CONFERENCE 2005-03-15 00:00:00-2005-03-16 00:00:00 University College, Dublin, Ireland 15 – 16 March 2005 View Conference Website 0
331009 RESULTS
CONFERENCE 2005-03-15 00:00:00-2005-03-16 00:00:00 University College, Dublin, Ireland 15 – 16 March 2005 View Conference Website 0
CONFERENCE 2005-03-10 00:00:00-2005-03-10 00:00:00 New York Academy of Medicine, New York, NY, U.S.A. 10 March 2005 Journalists are welcome to attend a symposium with a comprehensive approach to the latest treatments for dementia. It will focus on the best medicines, new ways to collaborate with family me
CONFERENCE 2005-03-09 00:00:00-2005-03-09 00:00:00 Hilton Sorrento Palace- Tritone Room, Sorrento, Italy 09 March 2005 It is our pleasure to invite you to participate in a unique satellite meeting to be held in conjunction with the AD/PD conference in Sorrento, Italy. The one-day meeting will take place o
MUTATIONS PSEN1 73640395 GRCh37/hg19 rs63750588 T A g.25663T> A g.42217T> A Exon 5 Point, Missense Coding Dramatically decreased Aβ40 and Aβ42 production, as well as decreased endopeptidase activity, in vitro. Unknown, MRI and SPECT showed atrophy and hypoper
MUTATIONS PSEN1 73640392 GRCh37/hg19 rs63751441 C G g.25660C> G g.42214C> G Exon 5 Point, Missense Coding Decreased Aβ40 and Aβ42 production in vitro. Neuropathology consistent with AD in one case. L153V Alzheimer's Disease: PathogenicAlzheimer's D
MUTATIONS PSEN1 73640375 GRCh37/hg19 rs63750907 C T g.25643C> T g.42197C> T Exon 5 Point, Missense Coding Unknown; predicted probably damaging in silico. Unknown. T147I Alzheimer's Disease: PathogenicAlzheimer's Disease This mutation was detected in
CONFERENCE 2005-03-08 00:00:00-2005-03-08 00:00:00 University of Naples, Naples, Italy 08 March 2005 On the occasion of the 7th International AD/PD Conference in Sorrento, Italy, March 9-13, 2005, the APOPIS consortium will arrange for a satellite symposium to present their first-year results. The satelli
CONFERENCE 2005-03-07 00:00:00-2005-03-08 00:00:00 Central London, United Kingdom 07 – 08 March 2005 Key Topics: Considerations for end product enhancement Pricing and reimbursement issues examined through case studies Clinical challenges in drug development Commercial realitites in drug develop
CONFERENCE 2005-03-03 00:00:00-2005-03-09 00:00:00 Keystone Resort, Keystone, CO, U.S.A. 03 – 09 March 2005 When we consider the enormous number of cells that proliferate in an individual over the course of a lifetime, cancer is a remarkably rare occurrence. Two major and general checks on carci
CONFERENCE 2005-03-03 00:00:00-2005-03-05 00:00:00 Omni Shoreham Hotel, Washington, DC, U.S.A. 03 – 05 March 2005 This Seventh Annual Meeting of ASENT presents two plenary symposia and three specialized workshops on topics of timely interest for investigators and other professionals interested i
CONFERENCE 2005-05-02 00:00:00-2005-05-04 00:00:00 Okura Hotel, Amsterdam, Amsterdam, Netherlands 02 – 04 May 2005 View Conference Website 0
CONFERENCE 2005-03-01 00:00:00-2005-03-01 00:00:00 New York Academy of Medicine, New York, NY, U.S.A. 01 March 2005 bnivin@health.nyc.gov 0
COMMENT My memory of Larry is at a conference in Sweden. He gave a 20-minute talk that had about 230 slides. No joke. He had the slides set to advance automatically and talked continually, stream-of-consciousness style, with the slides changing about every five s
CONFERENCE 2005-03-01 00:00:00-2005-03-02 00:00:00 Renaissance, Washington, DC, U.S.A. 01 – 02 March 2005 This conference brings together experts from industry, academia and government involved in all areas of imaging: The how, why and when to apply, implement, assess or outsource imaging. This
CONFERENCE 2005-02-22 00:00:00-2005-02-25 00:00:00 Taos Convention Center, Taos, NM, U.S.A. 22 – 25 February 2005 Our understanding of how ubiquitin regulates cellular function has greatly expanded recently, spurred by discoveries of protein families involved in ubiquitin conjugation and de-conj
No filters selected